ReviewJournal of chemical information and modeling2026
25 Years of Cardiac Ion Channel QSAR: From hERG Dominance to Multi-Channel Modeling.
Review in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
In 2013 the Comprehensive In Vitro Proarrhythmia Assay (CiPA) initiative proposed multi-channel assessment for proarrhythmic risk evaluation, yet ligand-based predictive modeling has remained largely single-channel. To quantify and explain this mismatch, we survey 155 ligand-based modeling studies on cardiac ion channels (including conventional QSAR, machine learning, and pharmacophore- and other 3D ligand-based approaches) published between 2001 and mid-2026. Across this period, 88.4% of studies target hERG as their sole ion channel endpoint, a proportion that reflects data availability, regulatory incentives, and research inertia rather than scientific necessity. Although public data for Nav1.5 and Cav1.2 were sufficient for modeling years earlier, both channels received only isolated studies until 2022. Since then, multi-channel modeling has expanded substantially, with multiple groups now addressing the primary channels (hERG, Nav1.5, and Cav1.2) jointly. In contrast, the secondary channels (Kv7.1, Kv4.3, and Kir2.1) remain largely understudied: Kv4.3 and Kir2.1 are entirely unmodeled in the surveyed literature, and models for Kv7.1 remain scarce, likely due to the sparsity and heterogeneity of public data. A retrospective analysis of the reported model performance found no discernible improvements attributable to methodological advances. Reliability-related aspects, such as applicability domain and uncertainty quantification, were also rarely addressed. The field should treat joint modeling of the primary channels as the expected standard rather than a novel contribution. Other important aspects include the development of standardized benchmarks for multi-channel evaluation, integration with physiological models, and greater emphasis on prediction reliability. For the secondary channels, progress would additionally require coordinated data release or federated learning, methods suited to data-scarce targets, and community coordination, none of which individual research groups can establish alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.